الصفحة الرئيسية>>Lipids>> Glycerolipids>>(S)-Bromoenol lactone

(S)-Bromoenol lactone (Synonyms: (S)BEL)

رقم الكتالوجGC40679

(S) -Bromoenol lactone ((S) -BEL) هو مثبط لا رجعة فيه ، حلزوني ، قائم على آلية من فوسفوليباز A2β المستقل عن الكالسيوم (iPLA2β) الذي يثبط إطلاق الأراكيدونات الناجم عن الفازوبريسين من العضلات الملساء الأبهر الجرذ المستزرع (A10) الخلايا ذات IC 50 من 2 ميكرومتر

Products are for research use only. Not for human use. We do not sell to patients.

(S)-Bromoenol lactone التركيب الكيميائي

Cas No.: 478288-94-7

الحجم السعر المخزون الكميّة
500μg
43٫00
متوفر
1mg
77٫00
متوفر
5mg
321٫00
متوفر
10mg
514٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

The phospholipases are an extensive family of lipid hydrolases that function in cell signaling, digestion, membrane remodeling, and as venom components. The calcium-independent phospholipases (iPLA2) are a PLA2 subfamily closely associated with the release of arachidonic acid in response to physiologic stimuli. (S)-Bromoenol lactone ((S)-BEL) is an irreversible, chiral, mechanism-based inhibitor of calcium-independent phospholipase β (iPLA2β) that inhibits the vasopressin-induced release of arachidonate from cultured rat aortic smooth muscle (A10) cells with an IC50 value of 2 µM. (S)-BEL is more than 1,000-fold selective for iPLA2 versus cPLA2, and is 10-fold selective for iPLA2β versus iPLA2γ.

مراجعات

Review for (S)-Bromoenol lactone

Average Rating: 5 ★★★★★ (Based on Reviews and 1 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for (S)-Bromoenol lactone

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.